ANUH PHARMA
Back to Balance Sheet
|
ANUH PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-3.86 Cr | ₹-2.08 Cr | ₹-0.42 Cr | ₹-0.77 Cr | ₹0.05 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ANUH PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-3.86 Cr |
| Mar2025 | ₹-2.08 Cr |
| Mar2024 | ₹-0.42 Cr |
| Mar2023 | ₹-0.77 Cr |
| Mar2022 | ₹0.05 Cr |
How is Deferred Tax Assets / Liabilities of ANUH PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-3.86 Cr | Negative | |
| Mar2025 | ₹-2.08 Cr | Negative | |
| Mar2024 | ₹-0.42 Cr | Negative | |
| Mar2023 | ₹-0.77 Cr | Negative | |
| Mar2022 | ₹0.05 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ANUH PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANUH PHARMA | ₹832.2 Cr | 2.2% | -7.1% | 1.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.1% | -5% | 5.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,762.0 Cr | -1.7% | 0.2% | 39.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -2.5% | -5.5% | 30.2% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 0.9% | -2.6% | -14.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,820.0 Cr | 0.1% | 7.6% | -3.5% | Stock Analytics | |
ANUH PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | 2.2% |
-7.1% |
1.4% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses